Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Model No.: DM 1032900-25-6
Function: Specialist Drugs
Certification: GMP
Grade Standard: Medicine Grade
Type: Chemical Reagent
State: Solid
Volatile: Not Volatile
Purity: 99%
Appearence: White Powder
Packaging: As required
Productivity: Stock available
Transportation: Ocean,Air
Place of Origin: Hebei,China
Supply Ability: As per order
Certificate: ISO9001
Port: Shanghai,Shenzhen,Qingdao
Payment Type: L/C,T/T,D/P,Paypal
Incoterm: FOB,CIF,CIP
Top Quality Good Price API Ceritinib CAS NO.1032900-25-6
Ceritinib is a new ALK gene inhibitor (ALKi) developed by Novartis Pharmaceuticals; its commercial name is Zykadia, and its previous code was LDK378. It was approved by the FDA for sale on April 29, 2014, and it is used to treat anaplastic lymphoma kinase (ALK) positive transfer of crizotinib (CRZ) progress or intolerance of non-small cell lung cancer (NSCLC).
Package&Shipping:
Double PE Bag with Foil Bag or as required
Delivery time:Stock Available
Port:Any port in China
Product Categories : APIs And Intermediates > APIs Powder
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now